Education
About Us
Working with TipRanks
Follow Us
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -22.67M | $ -16.14M | $ -8.22M | $ -1.35M | $ -453.85K |
| EBITDA | $ -22.56M | $ -16.14M | $ -8.22M | $ -24.20M | $ -451.53K |
| Net Income | $ -21.61M | $ -15.43M | $ -8.23M | $ -24.38M | $ -1.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.68M | $ 17.51M | $ 13.44M | $ 17.64M | $ 391.09K |
| Total Assets | $ 22.95M | $ 19.93M | $ 14.91M | $ 18.19M | $ 539.60K |
| Total Debt | $ 1.07M | $ 0.00 | $ 0.00 | $ 50.00K | $ 4.10M |
| Net Debt | $ -16.61M | $ -17.51M | $ -13.44M | $ -17.59M | $ 3.71M |
| Total Liabilities | $ 9.70M | $ 3.72M | $ 1.75M | $ 202.04K | $ 5.27M |
| Stockholders' Equity | $ 13.25M | $ 16.41M | $ 13.16M | $ 17.99M | $ -4.73M |
| Cash Flow | |||||
| Free Cash Flow | $ -15.77M | $ -11.42M | $ -7.41M | $ -1.59M | $ -404.69K |
| Operating Cash Flow | $ -14.60M | $ -11.37M | $ -7.41M | $ -1.59M | $ -404.69K |
| Investing Cash Flow | $ -1.18M | $ -52.09K | $ 0.00 | $ -802.00 | $ 0.00 |
| Financing Cash Flow | $ 15.95M | $ 15.46M | $ 3.23M | $ 18.85M | $ 0.00 |
Immix Biopharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.